Takeda Pharmaceutical has agreed to sell a selection of the over-the-counter (OTC) and prescription drugs it markets in Europe to fast-growing Danish pharma Orifarm for a total of about $670 million.
Latest Images
Trending Articles
More Pages to Explore .....